FDA Grants Clearance for NYU Startup UltraSight’s Cardiac Ultrasound Technology
NYU Startup UltraSight has been granted FDA clearance for its AI-powered ultrasound guidance technology. UltraSight’s AI guidance software assists medical …
News about TOV and NYU’s commercialization successes.
NYU Startup UltraSight has been granted FDA clearance for its AI-powered ultrasound guidance technology. UltraSight’s AI guidance software assists medical …
Aethon’s HapImmune™ platform, described in a recent publication in the journal Cancer Discovery, unites immunotherapy and targeted therapy. $30M in Series A …
Researchers at NYU Langone will gain access to Deerfield Management’s capital, infrastructure, and specialized resources to help advance novel therapeutics …
An AUTM member for two decades, Dr. Chitale welcomes the opportunity to represent AUTM’s membership, support the strategic vision of …
NYU Langone Health today announced the appointment of nationally renowned biotech and technology innovation expert Marc Sedam as its new …